Physician profile
Herbert M Green
NPI 1619919552
$5,580.85
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,218 · 2020: $1,279 · 2021: $766 · 2022: $318.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $907.11 | 2019-2022 | |
| Novo Nordisk INC | $793.12 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $577.45 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $461.73 | 2019-2021 | |
| Lilly USA, LLC | $434.34 | 2019-2021 | |
| Allergan, INC. | $419.77 | 2019-2020 | |
| Glaxosmithkline, LLC. | $393.08 | 2019-2021 | |
| Pfizer INC. | $357.70 | 2019-2021 | |
| Amgen INC. | $333.65 | 2019-2021 | |
| Amarin Pharma, INC. | $203.85 | 2019-2021 | |
| Astellas Pharma US INC | $149.07 | 2019-2021 | |
| Abbvie INC. | $127.98 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.37 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $63.25 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.02 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $49.65 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $40.41 | 2019 | |
| Circassia INC. | $24.37 | 2019 | |
| Corcept Therapeutics | $22.76 | 2019 | |
| Esperion Therapeutics, INC. | $20.71 | 2021 | |
| Mylan Specialty L.P. | $15.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.29 | 2020 | |
| Merck Sharp & Dohme LLC | $11.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.